John Cullity

About John Cullity

John is Managing Director at BioSynergy Partners, a New York and Melbourne based advisory spun out of Torreya – the renown life sciences investment bank. He additionally services on the Boards of several life sciences companies including Race Oncology listed on ASX and HaemaLogiX. He resides in New York. At Torreya, John provided strategic advisory on Mergers & Acquisitions, Partnering and Financing to life-science companies worldwide. Prior to joining Torreya, he was a senior member of the Business Development team at Sanofi Pharmaceuticals, where he led buy-side transactions in oncology and diabetes. Earlier in his career, John was Head of Strategic Pricing & Reimbursement at Sanofi, Director of Health Economics at Schering-Plough, and Consultant at A.T. Kearney. He has also worked at The World Bank and the World Health Organization. John graduated in Medicine and sub-specialised in haematology-oncology at QE II Medical Centre, Perth. He holds a Bachelor of Medicine, Bachelor of Surgery from The University of Western Australia; Membership of the Royal College of Physicians; Masters in Health Economics from London School of Economics & Political Science, and MBA from The Wharton School, University of Pennsylvania.

Experience

1. Chairman

   Racura Oncology

   May 2018 — Present · Sydney, AU

   Race Oncology is a specialty pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field.

Education

• The Wharton School

  MBA

  1997 — 1999

• The London School of Economics and Political Science (LSE)

  MSc (Econs)

  1995 — 1996

• The University of Western Australia

  Bachelor of Medicine

  1983 — 1988

• London School of Hygiene and Tropical Medicine, U. of London

  DTM&H

  1995 — 1995

• Royal College of Physicians, London

  MRCP

  1994 — 1995